Replies to post #33070 on Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

Basically no new revenue, its is merely recognizing a part of the previously announced $300k.

This company is insolvent. $32K in cash and $900k in assets yet they owe over $4m in accrued interest alone and another $7m in notes.

They are going so low as to now guarantee profits of 18% to its note holders or they issue them more shares to make up the difference. It is an unethical and questionable way to weasel around laws preventing people from guaranteeing investments, which is ILLEGAL!